Gliatech (GLIA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Torben Noerup Nielsen who wrote (1480)	3/10/2000 8:53:00 AM
From: Dr. John M. de Castro	Read Replies (2) of 2001

Torben, I agree. this program has great potential. What I've posted is only the tip of the proverbial iceberg. This MAB may be useful for a wide range of problems from bypass to stroke to ARDS to arthritis. The research I've done so far, and I admit that its sketchy, suggests that the scientific and clinical basis of the program are very solid and well documented. GLIA is quietly developing what may become their most significant program. It will take a while for this to progress to the point where it has a major effect on the stock value. But, I'm amazed at the excellence and depth of GLIA's pipeline. IMHO, the pipeline is superior to biotechs with market valuations 10 times that of GLIA. Best regards John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next